Anti-Human IgG antibody [EPR4421]
| Name | Anti-Human IgG antibody [EPR4421] |
|---|---|
| Supplier | Abcam |
| Catalog | ab109489 |
| Prices | $387.00 |
| Sizes | 100 µl |
| Host | Rabbit |
| Clonality | Monoclonal |
| Isotype | IgG |
| Clone | EPR4421 |
| Applications | WB IHC-P |
| Species Reactivities | Human, Monkey |
| Antigen | Synthetic peptide (the amino acid sequence is considered to be commercially sensitive) (internal sequence) |
| Description | Rabbit Monoclonal |
| Gene | IGHG1 |
| Conjugate | Unconjugated |
| Supplier Page | Shop |
Product images
![All lanes : Anti-Human IgG antibody [EPR4421] (ab109489) at 1/1000 dilutionLane 1 : IgG2 recombinant protein (10 ng protein loaded)Lane 2 : IgG1 recombinant protein (10 ng protein loaded)Lane 3 : IgG3 recombinant protein (10 ng protein loaded)Lane 4 : IgG4 recombinant protein (10 ng protein loaded)](http://www.bioprodhub.com/system/product_images/ab_products/2/sub_3/5687_Human-IgG-Primary-antibodies-ab109489-4.jpg)
All lanes : Anti-Human IgG antibody [EPR4421] (ab109489) at 1/1000 dilutionLane 1 : IgG2 recombinant protein (10 ng protein loaded)Lane 2 : IgG1 recombinant protein (10 ng protein loaded)Lane 3 : IgG3 recombinant protein (10 ng protein loaded)Lane 4 : IgG4 recombinant protein (10 ng protein loaded)
ab109489, at 1/500 dilution, staining Human IgG in paraffin-embedded Human tonsil tissue by Immunohistochemistry.
ab109489, at 1/500 dilution, staining Human IgG in paraffin-embedded Human stomach tissue by Immunohistochemistry.
Product References
An inflammatory myofibroblastic tumor exhibiting immunoreactivity to KIT: a case - An inflammatory myofibroblastic tumor exhibiting immunoreactivity to KIT: a case
Kataoka TR, Yamashita N, Furuhata A, Hirata M, Ishida T, Nakamura I, Hirota S, Haga H, Katsuyama E. World J Surg Oncol. 2014 Jun 18;12:186.
Long-term tumor regression induced by an antibody-drug conjugate that targets - Long-term tumor regression induced by an antibody-drug conjugate that targets
Sapra P, Damelin M, Dijoseph J, Marquette K, Geles KG, Golas J, Dougher M, Narayanan B, Giannakou A, Khandke K, Dushin R, Ernstoff E, Lucas J, Leal M, Hu G, O'Donnell CJ, Tchistiakova L, Abraham RT, Gerber HP. Mol Cancer Ther. 2013 Jan;12(1):38-47.